Novartis in Talks to Join Pharma Industry’s Covid Vaccine Push

Novartis AG is in talks to help produce other companies’ coronavirus vaccines or treatments as the industry mobilizes to boost supply amid fights over access.

The company is “in conversations with a range of different players,” Chief Executive Officer Vas Narasimhan said on Bloomberg TV, with an agreement possible in the coming days or weeks. “We have production capacity across our network that we’re willing to make available,” he said, for everything from monoclonal antibodies to vaccine production.